Skip to main content
Fig. 3 | Molecular Cancer

Fig. 3

From: The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy

Fig. 3

The properties of RBCM coated nanoparticles. A TEM image analysis and (B) the size distribution of MAIN. C TEM analysis and (D) the size distribution of REMAIN. E Nuclease protection assay of miR-126-3p. F SDS-PAGE analysis of REMAIN. G WB analysis of MMP2 levels. H The cumulative release of miR-126-3p in different conditions

Back to article page